CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Holdings History for Phathom Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (PHAT)

Symbol: PHAT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$6,601,327	397,910	+32,006	+8.7%	$16.59	Q4 2025
30 Sep 2025	0%	+0%	$4,306,690	365,904	+5,744	+1.6%	$11.77	Q3 2025
30 Jun 2025	0%	+0%	$3,453,934	360,160	+12,125	+3.5%	$9.59	Q2 2025
31 Mar 2025	0%	-0%	$2,182,179	348,035	-5,003	-1.4%	$6.27	Q1 2025
31 Dec 2024	0%	+0%	$2,866,669	353,038	+60,178	+21%	$8.12	Q4 2024
30 Sep 2024	0%	+0%	$5,294,909	292,860	+6,990	+2.4%	$18.08	Q3 2024
30 Jun 2024	0%	+0%	$2,944,461	285,870	+21,376	+8.1%	$10.30	Q2 2024
31 Mar 2024	0%	+0%	$2,808,926	264,494	+1,970	+0.75%	$10.62	Q1 2024
31 Dec 2023	0%	+0%	$2,396,844	262,524	+15,843	+6.4%	$9.13	Q4 2023
30 Sep 2023	0%	+0%	$2,558,082	246,681	+67,811	+38%	$10.37	Q3 2023
30 Jun 2023	0%	+0%	$2,561,418	178,870	+7,263	+4.2%	$14.32	Q2 2023
31 Mar 2023	0%	-0%	$1,225,274	171,607	-1,647	-0.95%	$7.14	Q1 2023
31 Dec 2022	0%	+0%	$1,943,910	173,254	+16,574	+11%	$11.22	Q4 2022
30 Sep 2022	0%	+0%	$1,737,000	156,680	+36,866	+31%	$11.09	Q3 2022
30 Jun 2022	0%	-0%	$1,012,000	119,814	-6,373	-5.1%	$8.45	Q2 2022
31 Mar 2022	0%	+0%	$1,718,000	126,187	+2,888	+2.3%	$13.61	Q1 2022
31 Dec 2021	0%	+0%	$2,426,000	123,299	+2,428	+2%	$19.68	Q4 2021
30 Sep 2021	0%	+0%	$3,880,000	120,871	+13,751	+13%	$32.10	Q3 2021
30 Jun 2021	0%	+0%	$3,627,000	107,120	+19,864	+23%	$33.86	Q2 2021
31 Mar 2021	0%	+0%	$3,278,000	87,256	+11,358	+15%	$37.57	Q1 2021
31 Dec 2020	0%	+0%	$2,522,000	75,898	+111	+0.15%	$33.23	Q4 2020
30 Sep 2020	0%	-0%	$2,780,000	75,787	-5,881	-7.2%	$36.68	Q3 2020
30 Jun 2020	0%	+0%	$2,688,000	81,668	+13,065	+19%	$32.91	Q2 2020
31 Mar 2020	0%	+0%	$1,772,000	68,603	+816	+1.2%	$25.83	Q1 2020
31 Dec 2019	0%	+0%	$2,111,000	67,787	+67,787	NEW	$31.14	Q4 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.